Investigating how microRNAs communicate between retinal cells to reduce inflammation and injury
Extracellular microRNA-mediated intercellular communication between retinal microglia and RPE
This study is looking at how tiny molecules called microRNAs move between important eye cells to help keep your retina healthy, and it hopes to find new ways to treat age-related macular degeneration by using special vesicles from retinal cells to reduce inflammation and injury in the eye.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma Hlth Sciences Ctr NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project ID | NIH-11195714 on NIH RePORTER |
What this research studies
This research focuses on understanding how small RNA molecules called microRNAs are transferred between retinal pigment epithelium (RPE) cells and microglia, which are crucial for maintaining retinal health. The study aims to explore the potential of engineered extracellular vesicles derived from RPE to communicate with microglia and mitigate retinal inflammation and injury. By examining the effects of these vesicles on aging retinal microglia, the research seeks to uncover new therapeutic strategies for age-related macular degeneration. Patients may benefit from insights gained about cellular communication in the retina and potential new treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults experiencing age-related macular degeneration or related retinal conditions.
Not a fit: Patients with retinal conditions unrelated to aging or those who do not have any retinal diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies that improve retinal health and reduce the impact of age-related macular degeneration.
How similar studies have performed: Previous studies have shown promise in using extracellular vesicles for cellular communication and therapeutic applications, indicating a potential for success in this novel approach.
Where this research is happening
Oklahoma City, United States
- University of Oklahoma Hlth Sciences Ctr — Oklahoma City, United States (Active)
Researchers
- Principal investigator: Cai, Jiyang — University of Oklahoma Hlth Sciences Ctr
- Study coordinator: Cai, Jiyang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.